Journals / Van Tıp Dergisi / 2017 / Cilt: 24 - Sayı: 4

Analysis of Relation between Alpha Fetoprotein and Gastric Cancer

Alfa Fetoproteinin, Mide Kanseri ile İlişkisinin İncelenmesi

Pages
346–351
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Distally located gastric cancers cases should be evaluated cautiously in patients whose AFP levels are in normal range.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: It has been reported that Alpha-fetoprotein (AFP) producing gastric cancers have a worse prognosis than those not producing.
📊
Key Findings & Data:Study was designed to collect data of gastric cancer patients in a prospective manner between dates 20142015 in a university health center.
💡
Conclusion & Impact:Distally located gastric cancers cases should be evaluated cautiously in patients whose AFP levels are in normal range.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: It has been reported that Alpha-fetoprotein (AFP) producing gastric cancers have a worse prognosis than those not producing. We aimed to investigate gastric cancers patients in regards of AFP producing cancers incidence and pathological variables of those not producing AFP. Materials and Method: Patients who had diagnosed with gastric adenocarcinoma and hospitalized in general surgery ward for operation were enrolled to the study. Study was designed to collect data of gastric cancer patients in a prospective manner between dates 20142015 in a university health center. Patients' blood samples were collected before and after surgery for analyzing AFP. The relation between serum levels of AFP and histopathological variables were analyzed. Results: Totally 63 cases were evaluated. Increased AFP level was observed in 2 cases (incidence=3.17%). Serum AFPs were 1.520 ng/mL and 0.590 ng/mL in preoperative and postoperative period respectively (p<0.001). There were no relation between preoperative AFP levels and tumor stage and neurovascular invasion status. We observed that the correlation between preoperative AFP levels and number of metastatic lymph node was not significant (spearman's rho=-0.183, p=0.157). According to tumor location, there was significant difference in AFP levels (p=0.021). Conclusion: AFP producing gastric cancers is rare between patients who referred to our center. Tumor stage and AFP levels seems unrelated. Distally located gastric cancers cases should be evaluated cautiously in patients whose AFP levels are in normal range.

Özet

Amaç: Alfa-fetoprotein (AFP) üreten mide kanserlerinin üretmeyenlere göre daha kötü prognoza sahip olduğu bildirilmektedir. Bu çalışmada, merkezimizdeki AFP üreten mide kanserlerinin sıklığının araştırılması ve üretmeyen tiplerin patoloji sonuçlarının değerlendirilmesi amaçlandı. Gereç ve Yöntem: Mide adenokarsinomu tanısı almış ve ameliyat planı ile genel cerrahi servisine yatırılmış hastalar çalışmaya dâhil edildi. Çalışma 2014-2015 yılları arasında, mide kanseri tanısı almış vakaların verilerinin, prospektif olarak toplanması şeklinde tasarlandı. Hastalardan ameliyat öncesi ve sonrası kan örnekleri alınarak serum AFP düzeyi çalışıldı. Hastane sisteminde kayıtlı patoloji verileri ile AFP düzeylerinin ilişkisi irdelendi. Bulgular: Toplam 63 hasta değerlendirilmeye alındı. AFP yüksekliği 2 hastada saptandı (insidans= %3.17). Serum AFP düzeyi normal sınırlarda olan hastaların, ameliyat öncesi ve sonrası AFP miktarları sırasıyla; 1.520 ng/mL ve 0.590 ng/mL bulundu (p< 0.001). Ameliyat öncesi serum AFP düzeyi ile tümörün evresinin ve nörovasküler invazyon varlığının olup olmaması ilişkisiz bulundu. AFP düzeyi ile metastatik lenf nodu sayısının korelasyonun olmadığı saptandı ( Spearmen's rho= -0.183, p=0.157). Tümörün yerleşim yerine göre AFP düzeyleri arasında anlamalı fark saptandı (p=0.021). Sonuç: Merkezimize başvuran mide kanserleri arasında, AFP üreten tipler çok azdır. AFP düzeyi ile tümörün evresi ilişkisiz gözükmektedir. AFP düzeyi normal sınırlarda olan hastalarda göreceli olarak, distal yerleşimli tümörlerin daha dikkatli değerlendirilmesi önemlidir.

🔖

Cite This Article

ÇELİK, S., ÇOKLUK, E., YILMAZ, Ö., ALMALI, N., KOTAN, M. Ç. (2017). Analysis of Relation between Alpha Fetoprotein and Gastric Cancer. Van Tıp Dergisi, Cilt: 24 - Sayı: 4, 346–351. https://ajindex.com/articles/334007

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Bergstrand CG, Czar B. Demonstration of a new protein fraction in serum from the human fetus. Scand J Clin Lab Invest 1956; 8(2): 174
  2. Bourreille J, Metayer P, Sauger F, Matray F, Fondimare A. Existence of alpha feto protein during gastric-origin secondary cancer of the liver. Presse Med 1970; 78(28): 1277-1278
  3. Yamamura N, Kishimoto T. Epigenetic regulation of GATA4 expression by histone modification in AFP-producing gastric adenocarcinoma. Exp Mol Pathol 2012; 93(1): 35-39
  4. Kinjo T, Taniguchi H, Kushima R, Sekine S, Oda I, Saka M, et al. Histologic and immunohistochemical analyses of alpha-fetoprotein--producing cancer of the stomach. Am J Surg Pathol 2012; 36(1): 56-65
  5. Song DS, Bae SH. Changes of guidelines diagnosing hepatocellular carcinoma during the last ten-year period. Clin Mol Hepatol 2012; 18(3): 258-267
  6. Llovet JM, Ducreux M, Lencioni R, Di Bisceglie AM, Galle PR, Dufour JF, et al. European Association For The Study Of The L, European Organisation For R, Treatment Of C. EASLEORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 2012; 56(4): 908-943
  7. Sun W, Liu Y, Shou D, Sun Q, Shi J, Chen L, et al. AFP (alpha fetoprotein): who are you in gastrology? Cancer Lett 2015; 357(1): 43-46
  8. Hirajima S, Komatsu S, Ichikawa D, Kubota T, Okamoto K, Shiozaki A, et al. Liver metastasis is the only independent prognostic factor in AFPproducing gastric cancer. World J Gastroenterol 2013; 19(36): 6055-6061
  9. He R, Yang Q, Dong X, Wang Y, Zhang W, Shen L, et al. Clinicopathologic and prognostic characteristics of alpha-fetoprotein-producing gastric cancer. Oncotarget 2017; 8(14): 23817- 23830
  10. Shimakata T, Kamoshida S, Kawamura J, Ogane N, Kameda Y, Yanagita E, et al. Immunohistochemical expression profiles of solute carrier transporters in alpha-fetoprotein-producing gastric cancer. Histopathology 2016; 69(5): 812-821
  11. Qu B-G, Bi WM, Qu BT, Qu T, Han XH, Wang H et al. PRISMA-Compliant Article: Clinical Characteristics and Factors Influencing Prognosis of Patients With Hepatoid Adenocarcinoma of the Stomach in China. Medicine, (2016)95(15), e3399.
  12. Ahn HS, Lee HJ, Hahn S, Kim WH, Lee KU, Sano T, et al. Evaluation of the seventh American Joint Committee on Cancer/International Union Against Cancer Classification of gastric adenocarcinoma in comparison with the sixth classification. Cancer 2010; 116(24):5592-2298.